Last month, we saw the networking
program in action with strong Goldman Prize participation at two major conferences: The Green Asia Forum and Europarc.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing
programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development
programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions
with respect to the B787
program; 4) margin pressures and the potential for additional forward losses on new and maturing
programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements
with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements
with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts
with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships
with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging
programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory
actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing
program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance
with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Neytanyahu delivered a visual - heavy presentation Monday that claimed to prove Tehran secretly pursued developing nuclear weapons,
in a bid to undermine support for the Joint Comprehensive Plan of
Action (JCPOA), the 2015 agreement signed
with six major world powers to curb its nuclear
program in exchange for economic sanctions relief.
«We'll be working
with the NTSB to make sure we understand the root cause, and any further
actions we need to take
in terms of maintenance or inspections we'll want to add to our
program.»
Use of Name and Likeness: By posting User Content on the online services, you consent to the recording, use and reuse by NBCUniversal, its licensees, successors and assigns, of your voice,
actions, likeness, name, appearance, profile photograph, performance, biographical material, and any other identifying information, including, without limitation, any information contained
in your User Content (collectively, «Personal Elements»), as used, edited, altered, fictionalized or modified by NBCUniversal,
in its sole discretion,
in any and all media now known or hereafter devised, throughout the world,
in perpetuity, including, without limitation,
in and
in connection
with NBCUniversal, or related Sites or online services,
in and
in connection
with any television
programs and other productions, and
in and
in connection
with advertising, promotion and publicity.
This obsession
with metrics has led to initiatives like affirmative
action hiring
programs set up by some of the biggest names
in tech, which, unfortunately, have failed to perform as hoped.
The PCAOB said
in its own statement that it «has cooperated
with and appreciates the government's
actions to preserve and reinforce the integrity of the PCAOB's regulatory oversight
programs that protect investors who rely on the audits of public companies.»
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations
with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government
action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination
with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed
with the U.S. Securities and Exchange Commission (the SEC).
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships
with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including
with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes
in existing laws or regulations; the outcome of litigation, regulatory audits, investigations,
actions and / or guaranty fund assessments; uncertainties surrounding participation
in government - sponsored
programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated
with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed
in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
A hands - on
program that starts
with gamified pre-work and ends
with key takeaways and
actions to prepare for disruptions
in talent acquisition, corporate learning, and leadership development!
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services
in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated
with BlackBerry's foreign operations, including risks related to recent political and economic developments
in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated
with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE
program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances
with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities
in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of
actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated
with acquisitions; foreign exchange risks; and difficulties
in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.
With a smart contract functionality, the BCH chain can be used to
program autonomous
actions like dispersing BCH to your children or spouse at a later date
in time.
The Enrollment
Program also authorizes a superior court to have jurisdiction over enrollees by allowing it to «appoint a receiver, monitor, conservator, or other designated fiduciary or officer of the court for a defendant or the defendant's assets,» as well as authorizes the Commissioner of Business Oversight to «include
in civil
actions claims for ancillary relief, including restitution and disgorgement, on behalf of a person injured, as well as attorney's fees and costs, and civil penalties of up to $ 25,000» for up to four years after the purported violation occurred and «refer evidence regarding violations of the bill's provisions to the Attorney General, the Financial Crimes Enforcement Network of the United States Department of the Treasury, or the district attorney of the county
in which the violation occurred, who would be authorized,
with or without this type of a reference, to institute appropriate proceedings.»
The bill appears to be heading toward the finish line, though at least three other Republican senators remained publicly undecided on Friday, including Mike Lee of Utah, who has allied
with Mr. Rubio
in pressing for an expanded child credit, and Jeff Flake of Arizona, who has been trying to extract commitments from Republican leadership related to the Deferred
Action for Childhood Arrivals, or DACA,
program.
As the Fed's stimulus
program appears to have «peaked» Citi warned investors yesterday to be cautious
with the Equity markets; and recent price
action across the Treasury curve suggests lower yields can be seen and US 10 year yields are
in danger of retesting the 2.40 % area.
Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines
in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated
with operating internationally; our expansion into and investments
in new markets; breaches
in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes
in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions
in the agreements governing our indebtedness that limit our flexibility
in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions
in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations
in foreign currency exchange rates; overcapacity
in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays
in our shipbuilding
program and ship repairs, maintenance and refurbishments; future increases
in the price of, or major changes or reduction
in, commercial airline services; seasonal variations
in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace
with developments
in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement
actions; changes involving the tax and environmental regulatory regimes
in which we operate; and other factors set forth under «Risk Factors»
in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company
with the Securities and Exchange Commission.
Just as those glued to their television sets for six or seven hours a night reasonably prefer sets
with PIP (picture
in picture) which let one see the
action of more than one channel at once, to enhance surfing (at the loss of coherence, if you value that), so, too, do workers chained to computer monitors for eight or more hours a day naturally prefer to have a large screen
with 16 million possible shades and hues of color,
with a number of
programs opened at once.
Standing
in front of the United Methodist Building near the U.S. Capitol, the «Nuns on the Bus,» as they have billed themselves, rallied an excited crowd
with stories from the road and a call to
action for future protests to protect social
programs.
Not only is there great promise
in such
programs for stimulating the poor to increase their own potential for dealing
with their problems, (For stimulating discussions of how social
action can help develop the human potential of those who participate, see the following articles: Peggy Way, «Community Organization and Pastoral Care: Drum Beat for Dialogue,» Pastoral Psychology, March, 1968 pp. 25 - 36; Rudolph M. Wittenberg, «Personality Adjustment Through Social Action,» in MHP, pp. 378
action can help develop the human potential of those who participate, see the following articles: Peggy Way, «Community Organization and Pastoral Care: Drum Beat for Dialogue,» Pastoral Psychology, March, 1968 pp. 25 - 36; Rudolph M. Wittenberg, «Personality Adjustment Through Social
Action,» in MHP, pp. 378
Action,»
in MHP, pp. 378 - 92.)
Rather, process thought as a world - view presents man
with a
program for
action in the present.
It dealt very forcefully
with the disregard of human rights
in the current inquisitions and then spoke of the fanatical negativism without any constructive
program of
action which is leading the American mind into a «spiritual vacuum.»
I envision such centers as organic - cybernetic institutions
with sensors bringing information from all important sources where the future is being formed and
in turn feeding back the results of reflections upon these influences to places where visions of desirable futures could be transformed into
programs of
action.
«They place stress on the individual as the foundational societal unit,
with a stress on the need for the individual to take
action in the form of being born again and supporting the
program.
Dedicated, knowledgeable churchmen have often seen the need to join forces
with others
in sparking a community - wide
action program, coordinated by an Alcoholism Council.
If death precedes resurrection, then while taking some of the
actions suggested
in this book may cause your church to die and disappear (again, the physical structure
with the building and
programs and paid staff), the true church of Jesus Christ may actually rise up to new life, light, vibrancy, and faithfulness!
Affirmative
action programs are being challenged; attitudes toward immigration have taken a restrictionist turn; and many white families seek to place their children
in schools
with few children of color.
In previous chapters I have suggested what concerned citizens can do to deal with television without censorship: create local television councils and community action to get stations to accept their responsibility for the public welfare; introduce media education courses in the schools and churches to create media literacy; organize community groups to develop programs relating to community issues on the «narrowcast» media of cable - TV, videocassettes, low - power TV, public - broadcasting facilities, and commercial side - band channels; employ stockholder action and other economic measure
In previous chapters I have suggested what concerned citizens can do to deal
with television without censorship: create local television councils and community
action to get stations to accept their responsibility for the public welfare; introduce media education courses
in the schools and churches to create media literacy; organize community groups to develop programs relating to community issues on the «narrowcast» media of cable - TV, videocassettes, low - power TV, public - broadcasting facilities, and commercial side - band channels; employ stockholder action and other economic measure
in the schools and churches to create media literacy; organize community groups to develop
programs relating to community issues on the «narrowcast» media of cable - TV, videocassettes, low - power TV, public - broadcasting facilities, and commercial side - band channels; employ stockholder
action and other economic measures.
Viewers are more likely to express influences of religious
programs in actions which are proximate to the television screen, such as contacting or subscribing to a religious broadcast organization rather than through the more distant option of initiating a relationship
with a neighborhood church.
Stop Hunger Now distinguishes itself from other aid / relief organizations
with a focus on engaging volunteers
in a hands - on activity to produce meals that are used strategically to support development
programs, while at the same time fostering the growth of a movement to end hunger by educating those volunteers about the need and giving them an opportunity to take
action.
The next farm bill must include support and adequate funding for the USDA National Organic
Program (NOP) to keep pace
with industry growth, set uniform standards, and carry out compliance and enforcement
actions in the U.S. and abroad.
The
action is being managed
in partnership
with the Victorian Environmental Water Holder, Goulburn - Broken Catchment Management Authority, Goulburn - Murray Water and the Living Murray
program.
The
program gives girls self - esteem enhancing tools, tips on how to develop and maintain healthy relationships
with their peers and
action plans on how to handle bullying situations
in life that match their own personalities.
The Golden Eagles fired a
program record 32 - under - par
in order to bring that trophy home, led by Oliver Farrell snagging the individual title
with a 14 - under - par 202 across three rounds of
action.
Schools involved
in our
program send full teams to attend intensive conferences where they work
with a coach to design
action plans to implement best practices
in areas such as curriculum, assessment, homework, school schedule, and a healthy school climate.
School Nutrition Foundation invites you to join us as we kick off our 2013 - 14 «Webinar Wednesday» series on Wednesday, September 11, 2013 when we will present «Connecting Schools and Communities through the Afterschool Meal
Program»
in partnership
with the Food Research and
Action Center (FRAC) and the Afterschool Alliance.
He saw the
program in action when he was superintendent
in Anne Arundel County, where BIC was implemented
in 2006 along
with a host of other
programs like «Taste the Rainbow» efforts to improve fruit and vegetable consumption.
The Food Research and
Action Center's report, «Hunger Doesn't Take a Vacation,» said that nationally about 3.2 million children are enrolled
in summer nutrition
programs, compared
with 15.3 million who receive free and reduced - price lunches during the school year.
These pilot
programs were funded through the Partners for Breakfast
in the Classroom; along
with SNF, the partners include the Food Research and
Action Center (FRAC), National Association of Elementary School Principals Foundation (NAESPF), and National Education Association Health Information Network (NEAHIN), and funded by the Walmart Foundation.
Contacting local elected officials and youth sports
program directors
with your firsthand account of issues
in youth sports is a starting point for voicing your concerns, and directing them to the Recommendations for Communities not only shows that you are serious about your complaint but that you are also committed to resolving the issues by providing an
action plan.
You will witness first - hand our Kindergarten
Program in action and talk
with other parents who have experience
with Waldorf.
The providers may be credentialed or certified professionals, paraprofessionals, or volunteers, but typically they have received some form of training
in the methods and topical content of the
program so that they are able to act as a source of expertise for caregivers.3 Finally, home visiting
programs are attempting to achieve some change on the part of participating families —
in their understanding (beliefs about child - rearing, knowledge of child development), and / or
actions (their manner of interacting
with their child or structuring the environment)-- or on the part of the child (change
in rate of development, health status, etc.).
Integrated Management of Childhood Illness (IMCI)- Part III - Chapter 11 - Breastfeeding Nutrient adequacy of exclusive breastfeeding for the term infant during the first six months of life (2002) Geneva, World Health Organization Full text [pdf 278kb] The optimal duration of exclusive breastfeeding: a systematic review Geneva, World Health Organization, 2001 Full text [pdf 1.06 Mb] Report of the expert consultation of the optimal duration of exclusive breastfeeding Report of an expert consultation Geneva, World Health Organization, 28 - 30 March 2001 Full text [pdf 122kb] The WHO Global Data Bank on Infant and Young Child Feeding Breastfeeding and Complementary Feeding Feeding Your Baby From Six Months To One Year Your guide to help you introduce food to your baby Adapted and reproduced
with permission of Peel Public Health, Region of Peel A Practical Workbook to Protect, Promote and Support Breastfeeding
in Community Based Projects Health Canada, Ottawa, 2002 This workbook is intended to assist the Canada Prenatal Nutrition
Program (CPNP) or similar community based prenatal projects to identify strategies and specific
actions to protect, promote and support breastfeeding
in a population health context.
The new School Meal Flexibility Rule... reflects USDA's commitment, made
in a May proclamation to work
with program operators, school nutrition professionals, industry, and other stakeholders to develop forward - thinking strategies to ensure school nutrition standards are both healthful and practical... This
action reflects a key initiative of USDA's Regulatory Reform Agenda, developed
in response to the President's Executive Order to alleviate unnecessary regulatory burdens.
Effective food policy
actions are part of a comprehensive approach to improving nutrition environments, defined as those factors that influence food access.1 Improvements
in the nutritional quality of all foods and beverages served and sold
in schools have been recommended to protect the nutritional health of children, especially children who live
in low - resource communities.2 As legislated by the US Congress, the 2010 Healthy Hunger - Free Kids Act (HHFKA) updated the meal patterns and nutrition standards for the National School Lunch
Program and the School Breakfast
Program to align
with the 2010 Dietary Guidelines for Americans.3 The revised standards, which took effect at the beginning of the 2012 - 2013 school year, increased the availability of whole grains, vegetables, and fruits and specified weekly requirements for beans / peas as well as dark green, red / orange, starchy, and other vegetables.
Get Moving And Apply For An
Action For Healthy Kids School Grant Designed
With Parents
In Mind Parents can be a formidable force for change in schools, especially when it comes to starting health and wellness program
In Mind Parents can be a formidable force for change
in schools, especially when it comes to starting health and wellness program
in schools, especially when it comes to starting health and wellness
programs.
The National Volunteer Caregiving Network started as the Faith
in Action program in 1983
with funds from The Robert Wood Johnson Foundation.
Our 2013 - 14 «Webinar Wednesdays» series has begun, and our new topic will be presented on Wednesday, October 16, 2013; join us for «Sustainable Breakfast -
in - the - Classroom
Programs Start
with Effective Assessments» at 2:00 p.m. EST for a 75 minute webinar that will help you understand the assessment process, which provides the framework for the development of a district breakfast -
in - the - classroom (BIC)
action plan.
As expected, the Department of Homeland Security said it would shut down the Deferred
Action for Childhood Arrivals
program in six months — what officials called an «orderly wind down» —
with the intent of giving Congress time for a potential legislative fix.
Speaker Quinn, Councilman Gennaro,
in conjunction
with CUNY Citizenship Now, is participating
in a new collaborative citywide
program that offers free help
with immigration questions related to naturalization and deferred
action for childhood arrivals.
Oneida County's Lead Primary Prevention
Program (LPP),
in cooperation
with the Mohawk Valley Community
Action Agency (MVCAA), will partner
with other community agencies to provide medical and dental screenings and services for children enrolled
in the HeadStart
Program, Oneida County Executive Anthony J. Picente, Jr. announced today... Read more